Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528405 (5-(4-Chloro-3-methoxyphenyl)-2-(4-chlorophenyl)-[1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528519 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-benzyl-[1,2,4...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528477 (5-(Benzo[d][1,3]dioxol-5-yl)-2-(4-chlorophenyl)-[1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528478 (5-(2-Methoxyphenyl)-2-phenyl-[1,2,4]triazolo[1,5-a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528479 (2,5-Diphenyl-[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528480 (5-(4-Methoxyphenyl)-2-phenyl-[1,2,4]triazolo[1,5-a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528481 (5-(3-Methoxyphenyl)-2-phenyl-[1,2,4]triazolo[1,5-a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528482 (2-(4-Chlorophenyl)-5-(4-methoxyphenyl)-[1,2,4]tria...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528483 (2-(4-Methoxyphenyl)-5-phenyl-[1,2,4]triazolo[1,5-a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528484 (2-(2-Chlorophenyl)-5-phenyl-[1,2,4]triazolo[1,5-a]...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528485 (5-(3,4-Dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyri...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528486 (5-(4-Methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidi...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528487 (5-(Benzo[d][1,3]dioxol-5-yl)-2-benzyl-[1,2,4]triaz...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528488 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(pyridin-2-yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528489 (5-(1H-Indazol-5-yl)-2-(pyridin-2-yl)-[1,2,4]triazo...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528490 (5-(1H-indazol-5-yl)-2-methyl-[1,2,4]triazolo[1,5-a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528491 (2-Ethyl-5-(1H-indazol-5-yl)-[1,2,4]triazolo[1,5-a]...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528492 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-ethyl-[1,2,4]...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528493 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-N-methyl-7-oxo-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528405 (5-(4-Chloro-3-methoxyphenyl)-2-(4-chlorophenyl)-[1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528476 (5-(4-Chloro-3-methoxyphenyl)-2-(4-fluorophenyl)-[1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528494 (2-(3,4-Dichlorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528495 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(3,4-dichloro...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528496 (2-(3-Chlorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]tria...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528497 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(3-chlorophen...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528498 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-isopropyl-[1,...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528477 (5-(Benzo[d][1,3]dioxol-5-yl)-2-(4-chlorophenyl)-[1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528499 (5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-methyl-[...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528500 (5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-[1,2,4]tri...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528501 (2-Benzyl-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-[...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528502 (2-Benzyl-5-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528503 (2-(4-Fluorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]tria...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528504 (5-(1-Ethyl-1H-indazol-5-yl)-2-(4-fluorophenyl)-[1,...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528505 (5-(1H-Benzo[d][1,2,3]triazol-6-yl)-2-(2-chlorophen...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528506 (5-(1H-benzo[d][1,2,3]triazol-6-yl)-2-o-tolyl-[1,2,...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528507 (5-(1H-benzo[d][1,2,3]triazol-6-yl)-7-oxo-4,7-dihyd...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528508 (US11191765, Example 25) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528486 (5-(4-Methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidi...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528510 (5-(4-Methoxyphenyl)-2-methyl-[1,2,4]triazolo[1,5-a...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528511 (5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-(pyridin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528512 (5-(Benzo[d][1,3]dioxol-5-yl)-2-(pyridin-2-yl)-[1,2...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528482 (2-(4-Chlorophenyl)-5-(4-methoxyphenyl)-[1,2,4]tria...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528513 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(4-chlorophen...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528514 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(4-fluorophen...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528515 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-phenyl-[1,2,4...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528516 (2-(4-Chlorophenyl)-5-(1-ethyl-1H-indazol-5-yl)-[1,...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528517 (5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-methyl-[1,2,4...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528518 (2-(4-Chlorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]tria...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase (Homo sapiens (Human)) | BDBM528476 (5-(4-Chloro-3-methoxyphenyl)-2-(4-fluorophenyl)-[1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V1280S | |||||||||||
More data for this Ligand-Target Pair |